Generic · Injection · Updated Nov 11, 2026
Enoxaparin 100 mg/mL injection price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for enoxaparin 100 mg/ml injection and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Enoxaparin 100 mg/mL price history
What pharmacies pay for 3 mL, weekly- Now
- $29.93
- 52-week low
- $29.62
- 52-week high
- $34.92
- A year ago
- $34.29
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $9.87 | $9.98 | +1.0% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $10.27 | $9.87 | -3.8% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $9.93 | $10.27 | +3.4% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $9.88 | $9.93 | +0.5% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $10.19 | $9.88 | -3.1% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $10.97 | $10.19 | -7.2% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $11.23 | $10.97 | -2.3% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $10.75 | $11.23 | +4.6% | pharmacies' invoice prices changed (survey) |
Prices per mL. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for enoxaparin 100 mg/ml injection
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Shortages
- Lovenox, Injection, 40 mg/.4 mL (NDC 0075-0620-40)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Lovenox, Injection, 30 mg/.3 mL (NDC 0075-8013-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Enoxaparin Sodium, Injection, 40 mg/.4 mL (NDC 0955-1004-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Lovenox, Injection, 60 mg/.6 mL (NDC 0075-8016-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Enoxaparin Sodium, Injection, 120 mg/.8 mL (NDC 0955-1012-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Enoxaparin Sodium, Injection, 100 mg/1 mL (NDC 0955-1010-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Lovenox, Injection, 100 mg/1 mL (NDC 0075-8020-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Enoxaparin Sodium, Injection, 150 mg/1 mL (NDC 0955-1015-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Lovenox, Injection, 150 mg/1 mL (NDC 0075-2915-01)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Lovenox, Injection, 60 mg/.6 mL (NDC 0075-0621-60)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Enoxaparin Sodium, Injection, 30 mg/.3 mL (NDC 0955-1003-10)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
- Enoxaparin Sodium, Injection, 300 mg/3 mL (NDC 0955-1016-01)Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 7 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
5 companies sell enoxaparin 100 mg/ml injection under 7 package codes (NDCs). Pharmacies pay the same per mL whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Amphastar Pharmaceuticals, Inc. | 0548-5608-00 | $9.98 |
| BluePoint Laboratories | 68001-641-41 | $9.98 |
| Fresenius Kabi USA, LLC | 63323-539-03 | $9.98 |
| Meitheal Pharmaceuticals Inc. | 71288-426-03 71288-426-91 | $9.98 |
| Sanofi-Aventis U.S. LLC | 0955-1016-01 | $9.98 |
All 7 package codes
1 older package code is still priced but no longer in the current FDA listing.
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other enoxaparin strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 100 mg/mL, 0.3 mL prefilled syringe | $8.54 | $25.61 / 3 mL |
| 100 mg/mL, 0.4 mL prefilled syringe | $7.47 | $29.89 / 4 mL |
| 100 mg/mL, 0.6 mL prefilled syringe | $7.31 | $43.85 / 6 mL |
| 100 mg/mL, 0.8 mL prefilled syringe | $7.00 | $55.99 / 8 mL |
| 100 mg/mL, 1 mL prefilled syringe | $6.78 | $67.83 / 10 mL |
| 150 mg/mL, 0.8 mL prefilled syringe | $10.57 | $84.56 / 8 mL |
| 150 mg/mL, 1 mL prefilled syringe | $9.08 | $90.76 / 10 mL |
Official label & what changed
These highlights do not include all the information needed to use ENOXAPARIN SODIUM injection safely and effectively. See full prescribing information for ENOXAPARIN SODIUM injection.ENOXAPARIN SODIUM injection, for subcutaneous and intravenous useInitial U.S. Approval: 1993
WARNING: SPINAL/EPIDURAL HEMATOMAS
Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery
Optimal timing between the administration of enoxaparin sodium and neuraxial procedures is not known
Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary.
Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis [see Warnings and Precautions (5.1) and Drug Interactions (7)].
WARNING: SPINAL/EPIDURAL HEMATOMAS
See full prescribing information for complete boxed warning.
Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
Use of indwelling epidural catheters
Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants
A history of traumatic or repeated epidural or spinal punctures
A history of spinal deformity or spinal surgery
Optimal timing between the administration of enoxaparin sodium and neuraxial procedures is not known
Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary. (5.1, 7)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about enoxaparin 100 mg/ml injection
How much does enoxaparin 100 mg/ml injection cost without insurance?
Pharmacies pay about $29.93 for 3 mL ($9.98 per mL) as of November 11, 2026. A fair cash price is about $44.92: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $44.42 including shipping.
Is my price for enoxaparin 100 mg/ml injection fair?
Compare it with the fair cash price of $44.92 for 3 mL. Up to about $56.15 is fair; above $89.84 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is enoxaparin 100 mg/ml injection getting more expensive?
Over the last four weeks the price pharmacies pay rose 1.0%. Over a year it fell 12.7%. See the 52-week chart.
Who makes enoxaparin 100 mg/ml injection?
5 companies: Amphastar Pharmaceuticals, Inc., BluePoint Laboratories, Fresenius Kabi USA, LLC, Meitheal Pharmaceuticals Inc., Sanofi-Aventis U.S. LLC. See every package code.
Is enoxaparin in shortage?
Yes - 24 products are listed as short or being discontinued. Details.
Has enoxaparin been recalled?
7 recalls on record, 3 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about enoxaparin 100 mg/ml injection
No comments yet. Questions, tips, what worked for you - start the conversation.